Prosthetic heart valve obstruction: Thrombolysis or surgical treatment?

European Heart Journal: Acute Cardiovascular Care

Volumn 1, Issue 2, 2012, Pages 122-127

  Bonou, Maria ^a   Lampropoulos, Konstantinos ^a   Barbetseas, John ^a  

^a IASO GENERAL HOSPITAL   (Greece)

Author keywords

Pannus; prosthetic valve; thrombolysis; thrombosis

Indexed keywords

EID: 84990328098     PISSN: 20488726     EISSN: 20488734     Source Type: Journal    
DOI: 10.1177/2048872612451169     Document Type: Article

References (34)

1. Roudaut R, Serri K and Lafitte S. Thrombosis of prosthetic heart valves: diagnosis and therapeutic considerations. Heart 2007; 93: 137−142.
2. Daniels CJ, Barbetseas J Boudoulas H. Prosthetic valves. In: ACC (eds) Adult clinical cardiology self-assessment program, version 7. Washington, DC, American College of Cardiology, 2009, book 4, chapter 19, pp. 19.9.1–19.9.25.
3. Deviri E, Sareli P, Wisenbaugh T, et al. Obstruction of mechanical heart valve prostheses: clinical aspects and surgical management. J Am Coll Cardiol 1991; 17: 646–650.
4. Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007; 28: 230–268.
5. Butchart EG. Antithrombotic management in patients with prosthetic valves: a comparison of American and European guidelines. Heart 2009; 95: 430–436.
6. Yin W, Alemu Y, Affeld K, et al. Flow-induced platelet activation in bileaflet and monoleaflet mechanical heart valves. Ann Biomed Eng 2004; 32: 1058–1066.
7. Leguyader A, Watanabe R, Berbé J, et al. Platelet activation after aortic prosthetic valve surgery. Interact Cardiovasc Thorac Surg 2006; 5: 60–64.
8. Girdhar G and Bluestein D. Biological effects of dynamic shear stress in cardiovascular pathologies and devices. Expert Rev Med Device 2008; 5: 167–181.
9. Sun JC, Davidson MJ, Lamy A, et al. Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends. Lancet 2009; 374: 565–576.
10. Grunkemeier GL, Li HH, Naftel DC, et al. Long-term performance of heart valve prostheses. Curr Probl Cardiol 2000; 25: 73−154.
11. Aminian A, Lefebvre P, Delmotte P, et al. An unusual case of late bioprosthetic mitral valve thrombosis successfully managed with anticoagulation. Eur J Echocardiogr 2008; 9: 399–400.
12. Barbetseas J, Nagueh SF, Pitsavos C, et al. Differentiating thrombus from pannus formation in obstructed mechanical prosthetic valves: an evaluation of clinical, transthoracic and transesophageal echocardiographic parameters. J Am Coll Cardiol 1998; 32: 1410–1417.
13. Laplace G, Lafitte S, Labèque JN. et al. Clinical significance of early thrombosis after prosthetic mitral valve replacement: a postoperative monocentric study of 680 patients. J Am Coll Cardiol 2004; 43: 1283–1290.
14. Barbetseas J and Zoghbi WA. Evaluation of prosthetic valve function and associated complications. Cardiol Clin 1998; 16: 505–530.
15. Zoghbi WA, Chambers JB, Dumesnil JG, et al. Recommendations for evaluation of prosthetic valves with echocardiography and doppler ultrasound. J Am Soc Echocardiogr 2009; 22: 975–1014.
16. Barbetseas J, Crawford ES, Safi HJ, et al. Doppler echocardiographic evaluation of pseudoaneurysms complicating composite grafts of the ascending aorta. Circulation 1992; 85: 212–222.
17. Barbetseas J, Pitsavos C, Aggeli C, et al. Comparison of frequency of left atrial thrombus in patients with mechanical prosthetic cardiac valves and stroke versus transient ischemic attacks. Am J Cardiol 1997; 80: 526−528.
18. Tong AT, Roudaut R, Ozkan M, et al. Transesophageal echocardiography improves risk assessment of thrombolysis of prosthetic valve thrombosis: results of the international PRO-TEE registry. J Am Coll Cardiol 2004; 43: 77–84.
19. Capdeville M and Licina M. Assessment of prosthetic valves. In: Savage R and Aronson S (eds) Introperative transesophageal echocardiography. 1st ed. Philadelphia: Lippincott Williams & Wilkins, 2005, pp. 249–269.
20. Symersky P, Budde RP, De Mol BA, et al. Comparison of multidetector-row computed tomography to echocardiography and fluoroscopy for evaluation of patients with mechanical prosthetic valve obstruction. Am J Cardiol 2009; 104: 1128–1134.
21. Pibarot P and Dumesnil J. Valvular heart disease: Doppler echocardiographic evaluation of prosthetic valve function. Heart 2012; 98: 69−78.
22. Bonow RO, Carabello BA, Chatterjee K, et al. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008; 52: e1−e142.
23. Lengyel M, Horstkotte D, Völler H, et al. Working Group Infection, Thrombosis, Embolism and Bleeding of the Society for Heart Valve Disease. Recommendations for the management of prosthetic valve thrombosis. J Heart Valve Dis 2005; 14: 567−575.
24. Salem DN, O'Gara PT, Madias C, et al; American College of Chest Physicians. Valvular and structural heart disease: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 2008; 133: 593S–629S.
25. Roudaut R, Lafitte S, Roudaut MF, et al. Management of prosthetic heart valve obstruction: fibrinolysis versus surgery. Early results and long-term follow-up in a single-centre study of 263 cases. Arch Cardiovasc Dis 2009; 102: 269−277.
26. Cáceres-Lóriga FM, Pérez-López H, Morlans-Hernández K, et al. Thrombolysis as first choice therapy in prosthetic heart valve thrombosis. A study of 68 patients. J Thromb Thrombolysis 2006; 21: 185−190.
27. Nagy A, Dénes M and Lengyel M. Predictors of the outcome of thrombolytic therapy in prosthetic mitral valve thrombosis: a study of 62 events. J Heart Valve Dis 2009; 18: 268−275.
28. Keuleers S, Herijgers P, Herregods MC, et al. Comparison of thrombolysis versus surgery as a first line therapy for prosthetic heart valve thrombosis. Am J Cardiol 2011; 107: 275−279.
29. Karthikeyan G, Math RS, Mathew N, et al. Accelerated infusion of streptokinase for the treatment of left-sided prosthetic valve thrombosis: a randomized controlled trial. Circulation 2009; 120: 1108−1114.
30. Biteker M, Duran NE, Gunduz S, et al. Comparing different intravenous thrombolytic treatment regiments in patients with prosthetic heart valve thrombosis under the guidance of serial transesophageal echocardiography: a 15-year study in a single center (TROIA Trial). Circulation 2008; 118: S932.
31. Balasundaram RP, Karthikeyan G, Kothari SS, et al. Fibrinolytic treatment for recurrent left sided prosthetic valve thrombosis. Heart 2005; 91: 821−822.
32. Laurent M, Lelong B, Verhoye JP, et al. Prolonged heparin and vitamin K antagonist regimen for early non-obstructive thrombosis of mechanical mitral valve prostheses. J Heart Valve Dis 2008; 17: 533−541.
33. Lengyel M. Thrombolysis should be regarded as first-line therapy for prosthetic valve thrombosis in the absence of contraindications. J Am Coll Cardiol 2005; 45: 325, author reply 326.
34. Barbetseas J, Tsiachris D, Chrysohoou C. et al. Paraprosthetic leak unmasked by combined enoxaparin/warfarin therapy for thrombosed mitral valve. Echocardiography 2009; 26: 1105−1106.